IL6 and COVID-19: Persistent proinflammatory cells [IL-1, IL-6, and Tumor Necrosis Factor-α (TNF-α)] and altered cytokine production is suspected to have occurred during persistent inflammation in post COVID-19 conditions, revealed by a cytokine profiling study (40, 41).